The multivariate analysis showed that age > 60yrs, patients without lymph node metastasis, poor differentiated tumors and a high CEA level were independently associated with poorer prognosis. The gene discussed is CEACAM5; the disease is metastatic malignant neoplasm in the lymph nodes.